Navigation Links
Common antidepressant drugs linked to lactation difficulties in moms
Date:1/26/2010

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), women taking commonly used forms of antidepressant drugs may experience delayed lactation after giving birth and may need additional support to achieve their breastfeeding goals.

Breastfeeding benefits both infants and mothers in many ways as breast milk is easy to digest and contains antibodies that can protect infants from bacterial and viral infections. The World Health Organization recommends that infants should be exclusively breastfed for the first six months of life. This new study shows that certain common antidepressant drugs may be linked to a common difficulty experienced by new mothers known as delayed secretory activation, defined as a delay in the initiation of full milk secretion.

"The breasts are serotonin-regulated glands, meaning the breasts' ability to secrete milk at the right time is closely related to the body's production and regulation of the hormone serotonin," said Nelson Horseman, PhD, of the University of Cincinnati and co-author of the study. "Common antidepressant drugs like fluoxetine, sertraline and paroxetine are known as selective serotonin reuptake inhibitor (SSRI) drugs and while they can affect mood, emotion and sleep they may also impact serotonin regulation in the breast, placing new mothers at greater risk of a delay in the establishment of a full milk supply."

In this study, researchers examined the effects of SSRI drugs on lactation using laboratory studies of human and animal cell lines and genetically modified mice. Furthermore, an observational study evaluated the impact of SSRI drugs on the onset of milk production in postpartum women. In this study of 431 postpartum women, median onset of lactation was 85.8 hours postpartum for the SSRI-treated mothers and 69.1 hours for mothers not treated with SSRI drugs. Researchers commonly define delayed secretory activation as occurring later than 72 hours postpartum.

"SSRI drugs are very helpful medications for many moms, so understanding and ameliorating difficulties moms experience can help them achieve their goals for breastfeeding their babies," said Horseman. "More human research is needed before we can make specific recommendations regarding SSRI use during breastfeeding."


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. Complications common, often linked to trauma in children receiving cochlear implants
2. Deadly Choking Game Still Common Among Kids
3. Hard To Treat Diseases (HTDS) To Disperse Special One Time Hiru (HIRU) Common Stock
4. Obesity linked to common form of kidney cancer and each extra BMI point increases risk
5. National Fatigue Survey Examines Common Factors in Fatigue Across Chronic Medical Conditions
6. Common Radio Frequency Tag Readers Might Trouble Pacemakers
7. Heart Attacks More Common in Winter
8. Indoor Allergies Common in Winter
9. Melanoma Less Common in Blacks But Deadlier
10. Roper Industries Prices Public Offering of 2.3 Million Shares of Common Stock in Conjunction with Inclusion in the S&P 500(R)
11. Deadly infection more common than realized
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Dallas, TX (PRWEB) , ... ... ... HCC Risk Adjustment solution leverages advanced data analytics to accurately understand each ... ensure proper reimbursement for a given population. This new solution helps transform ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... just as effective on smaller and sometimes harder to reach ones, according to ... presented at the International Stroke Conference in Houston by Ricardo A. Hanel, MD, ...
(Date:2/22/2017)... ... ... Sideline Products participated in the World Horse Expo held in Timonium, MD ... production crew. Tom Seay’s program “Best of America by Horseback” is broadcasted on ... be featured on April 6, 2017. After the broadcast, the clip will be posted ...
(Date:2/22/2017)... ... February 22, 2017 , ... Using the power of the internet, ... online checklist. Over a period of just 24 months, thousands of individuals interested in ... checklist called T.A.D. , “The internet is not getting quieter. In fact it’s becoming ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ANGLESTRONG ... Kurt Angle, is now available on the App Store and Google ... mobile apps for the addiction and recovery industry, partnered with Angle to build ANGLESTRONG. ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... DIEGO , Feb. 22, 2017 ... first-in-class therapies for both rare and common malignancies, ... Series B financing. The company intends to use ... cirmtuzumab and TK216, and to advance preclinical development ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal ...
(Date:2/22/2017)... 2017 Kineta, Inc., a biotechnology company ... modulating therapies, today announced that KCP-400 (RgIA4), a ... (nAChR), demonstrates robust chronic pain relief and disease ... also establishes the a9a10 nAChR as a new, ... The findings were reported online in the February ...
Breaking Medicine Technology: